Advertisement

Canadian Journal of Public Health

, Volume 91, Supplement 1, pp S4–S9 | Cite as

Dernières données médicales sur l’hépatite C

  • Fondation canadienne du foie
  • Programme d’éducation nationale sur l’hépatite C
Article

Références

  1. 1.
    Organisation mondiale de la santé. Feuille d’information no 164 sur l’hépatite C. Genève, juin 1997.Google Scholar
  2. 2.
    Recommendations for the prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Morbidity and Mortality Weekly Report 1998;47:1–33. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.Google Scholar
  3. 3.
    McQuillan GM, Alter MJ, Moyer LA, et coll. A population-based serologic study of hepatitis C virus infection in the United States. In: Rizzetto M, Purcell RH, Gerin JL, Verme G (Eds.), Viral Hepatitis and Liver Disease, Turin: Edizioni Minerva Medica, 1997; 267–70.Google Scholar
  4. 4.
    Alter MJ, Hadler SC, Judson FN, et coll. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 1990;264:2231–35.CrossRefGoogle Scholar
  5. 5.
    An integrated protocol to manage health care workers exposed to blood borne pathogens. Can Commun Dis Rep 1997;23S2.Google Scholar
  6. 6.
    Prevention and Control of Hepatitis C: Guidelines and Recommendations. Can Commun Dis Rep 1995;21S2.Google Scholar
  7. 7.
    Stary A, Kopp W, Hoffman H, et coll. Seroepidemiologic study of hepatitis C virus in sexually transmitted disease risk groups. Sex Transm Dis 1992;19:252–58.CrossRefGoogle Scholar
  8. 8.
    Bodsworth NJ, Cunningham P, Kaldor J, Donovan B. Hepatitis C virus infection in a large cohort of homosexually active men: Independent associations with HIV-1 infection and injecting drug use but not sexual behaviour. Genitourin Med 1996;72:118–22.PubMedPubMedCentralGoogle Scholar
  9. 9.
    Alter MJ, Coleman PJ, Alexander WJ, et coll. Importance of heterosexual activity in the trans mission of hepatitis B and non-A, non-B hepati tis. JAMA 1989;262:1201–5.CrossRefGoogle Scholar
  10. 10.
    Thomas DL, Cannon RO, Shapiro CN, et coll. Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases. J Infect Dis 1994;169:990–95.CrossRefGoogle Scholar
  11. 11.
    Polish LB, Tong MJ, Co RL, et coll. Risk factors for hepatitis C virus infection among health care personnel in a community hospital. Am J Infect Control 1993;21:196–200.CrossRefGoogle Scholar
  12. 12.
    Sherman M. CASL Hepatitis Consensus Group. Management of viral hepatitis: Clinical and public health perspectives — a consensus statement. Can J Gastroenterol 1997;11:407–16.CrossRefGoogle Scholar
  13. 13.
    Fattovich G, Giustina G, Degos F, et coll. Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients. Gastro 1997;112:463–72.CrossRefGoogle Scholar
  14. 14.
    Koff RS, Dienstag JL. Extrahepatic manifestations of hepatitis C and the association with alcoholic liver disease. Semin Liver Dis 1995;15:101–9.CrossRefGoogle Scholar
  15. 15.
    NIH Consensus Conference on Management of Hepatitis C. Hepatology 1997;26:2S–10S.CrossRefGoogle Scholar

Copyright information

© The Canadian Public Health Association 2000

Authors and Affiliations

  • Fondation canadienne du foie
    • 1
  • Programme d’éducation nationale sur l’hépatite C
  1. 1.TorontoCanada

Personalised recommendations